109
Participants
Start Date
October 24, 2017
Primary Completion Date
June 28, 2019
Study Completion Date
February 28, 2020
Tandem Microsphere loaded with Epirubicin
The primary objective of this study is to evaluate the safety and efficacy of transcatheter arterial chemoembolization with Tandem Microspheres loaded with Epirubicin in the treatment of patients with localized hepatocellular carcinoma (HCC)
Beijing Cancer Hospital, Beijing
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
Guangdong Nanfang Hospital, Guangzhou
Henan Cancer Hospital, Zhengzhou
Zhongda Hospital Affiliated Southeast University, Nanjing
Shengjing Hospital Affiliated China Medical University, Shenyang
Shanghai Zhongshan Hospital, Shanghai
Second Aff. Hosp. of Zhejiang University College of Medicine, Hangzhou
The First Affiliated Hospital, Zhejiang University, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Lead Sponsor
Varian Medical Systems
INDUSTRY